Free Trial

WINTON GROUP Ltd Raises Position in Cronos Group Inc. (NASDAQ:CRON)

Cronos Group logo with Medical background
Remove Ads

WINTON GROUP Ltd increased its stake in shares of Cronos Group Inc. (NASDAQ:CRON - Free Report) by 106.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 288,990 shares of the company's stock after acquiring an additional 149,028 shares during the quarter. WINTON GROUP Ltd owned about 0.08% of Cronos Group worth $584,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Thompson Davis & CO. Inc. purchased a new stake in Cronos Group in the 4th quarter valued at $29,000. SBI Securities Co. Ltd. acquired a new position in Cronos Group in the fourth quarter valued at $30,000. Jones Financial Companies Lllp raised its holdings in shares of Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after buying an additional 6,520 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Cronos Group in the third quarter valued at about $37,000. Finally, Brooklyn FI LLC acquired a new stake in shares of Cronos Group during the fourth quarter worth about $96,000. Institutional investors and hedge funds own 8.71% of the company's stock.

Cronos Group Stock Down 1.1 %

CRON stock traded down $0.02 during trading on Tuesday, hitting $1.79. The company had a trading volume of 783,902 shares, compared to its average volume of 1,584,885. Cronos Group Inc. has a 1-year low of $1.72 and a 1-year high of $3.14. The firm has a 50-day moving average price of $1.92 and a 200-day moving average price of $2.03. The firm has a market cap of $684.73 million, a PE ratio of -13.77, a price-to-earnings-growth ratio of 1.74 and a beta of 0.89.

Remove Ads

Cronos Group Company Profile

(Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Read More

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads